Journey Medical Corporation
DERM
$7.42
$0.020.27%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.04% | 0.84% | -17.28% | -4.25% | -12.42% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.04% | 0.84% | -10.73% | -57.64% | -13.49% |
| Cost of Revenue | -13.76% | -20.19% | -0.49% | -17.79% | -26.26% |
| Gross Profit | 10.32% | 18.80% | -12.50% | -66.76% | -2.95% |
| SG&A Expenses | 15.05% | 25.52% | 2.23% | 31.96% | -14.93% |
| Depreciation & Amortization | 30.71% | 30.84% | -9.11% | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 0.58% | -28.79% | -34.42% | 1.32% | -17.99% |
| Operating Income | 1.74% | 67.06% | 206.18% | -116.78% | 35.10% |
| Income Before Tax | -11.16% | 60.99% | 178.43% | -114.16% | 59.81% |
| Income Tax Expenses | -- | -- | -51.59% | -- | -- |
| Earnings from Continuing Operations | -12.94% | 60.99% | 170.98% | -114.24% | 59.81% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -12.94% | 60.99% | 170.98% | -114.24% | 59.81% |
| EBIT | 1.74% | 67.06% | 206.18% | -116.78% | 35.10% |
| EBITDA | 14.20% | 75.65% | 349.42% | -111.52% | 38.62% |
| EPS Basic | 3.03% | 65.92% | 162.30% | -112.77% | 63.81% |
| Normalized Basic EPS | 4.57% | 65.91% | 168.84% | -118.67% | 42.00% |
| EPS Diluted | 3.03% | 65.92% | 156.68% | -115.00% | 63.81% |
| Normalized Diluted EPS | 4.57% | 65.91% | 168.84% | -121.33% | 42.00% |
| Average Basic Shares Outstanding | 16.49% | 14.44% | 14.00% | 11.52% | 11.05% |
| Average Diluted Shares Outstanding | 16.49% | 14.44% | 14.00% | -2.36% | 11.05% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |